Topical diclofenac usage among Medicare beneficiaries rose 1621% (2015-2019) independent of marketing, potentially reflecting therapeutic substitution driven by national efforts to reduce opioid prescribing.
Kanaka D. Shetty, MD, MS
Advertisement
Articles by Kanaka D. Shetty, MD, MS
Hospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.
Advertisement
Latest Updated Articles
- Actions to Improve Quality: Results From a National Hospital Survey
December 8th 2021
Rapid Increase in Topical Diclofenac Use for Chronic Pain, 2011-2020October 27th 2026
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms
3
US Measles Outbreaks Cost Nearly $83 Million in 2026
4
The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs
5